文献速递糖尿病

基于HOMA2β细胞功能与胰岛素敏感性指数的2型糖尿病亚组中多发性神经病变的患病率

The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity.
PubMed 文献 · Diabetes Care · 2023-01-01

在4388例新诊断2型糖尿病丹麦患者中,按HOMA2-B和HOMA2-S分为高胰岛素血症、经典和胰岛素缺乏三个亚组,中位随访3年后3397例(77%)完成MNSIq问卷。高胰岛素血症组糖尿病多发性神经病变(DPN)患病率为23%,经典组16%,胰岛素缺乏组14%;校正后高胰岛素血症组较经典组的DPN患病率比为1.35(95%CI 1.15-1.57)。

要点

  • 高胰岛素血症组DPN患病率为23%,经典组16%,胰岛素缺乏组14%。
  • 校正代谢综合征组分等因素后,高胰岛素血症组较经典组DPN患病率比为1.35(95%CI 1.15-1.57)。
  • 样条分析显示DPN患病率随HOMA2-B升高呈线性关系,独立于代谢综合征组分和HOMA2-S。

核心结论

  • 以高HOMA2-B为标志的高胰岛素血症可能是独立于代谢综合征组分和胰岛素抵抗之外的重要DPN危险因素。
  • 作者认为在制定预防DPN的干预措施时应考虑这一点。

研究设计与样本

  • 研究纳入4388例新诊断2型糖尿病的丹麦患者,依据HOMA2-B和HOMA2-S分为高胰岛素血症(高HOMA2-B、低HOMA2-S)、经典(低HOMA2-B、低HOMA2-S)和胰岛素缺乏(低HOMA2-B、高HOMA2-S)三个亚组。
  • 中位随访3年后,患者填写密歇根神经病变筛查量表问卷(MNSIq),以评分≥4分识别DPN。
  • 采用泊松回归计算校正患病率比(PR),并用样条模型检验与HOMA2-B和HOMA2-S的关联。

主要发现

  • 共3397例(77%)患者完成MNSIq问卷。
  • DPN患病率在高胰岛素血症组为23%,经典组为16%,胰岛素缺乏组为14%。
  • 校正人口学特征、糖尿病病程和治疗、生活方式行为以及代谢综合征组分(腰围、甘油三酯、HDL胆固醇、高血压和HbA1c)后,高胰岛素血症组较经典组的DPN患病率比为1.35(95%CI 1.15-1.57)。
  • 样条分析显示,DPN患病率随HOMA2-B升高呈线性关系,独立于代谢综合征组分和HOMA2-S。

关键数值与推荐

  • DPN定义:MNSIq评分≥4分。
  • 高胰岛素血症组较经典组校正后DPN患病率比PR=1.35(95%CI 1.15-1.57)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Metabolic syndrome components may cumulatively increase the risk of diabetic polyneuropathy (DPN) in type 2 diabetes mellitus (T2DM) patients, driven by insulin resistance and hyperinsulinemia. We investigated the prevalence of DPN in three T2DM subgroups based on indices of β-cell function and insulin sensitivity. RESEARCH DESIGN AND METHODS: We estimated β-cell function (HOMA2-B) and insulin sensitivity (HOMA2-S) in 4,388 Danish patients with newly diagnosed T2DM. Patients were categorized into subgroups of hyperinsulinemic (high HOMA2-B, low HOMA2-S), classical (low HOMA2-B, low HOMA2-S), and insulinopenic (low HOMA2-B, high HOMA2-S) T2DM. After a median follow-up of 3 years, patients filled the Michigan Neuropathy Screening Instrument questionnaire (MNSIq) to identify DPN (score ≥ 4). We used Poisson regression to calculate adjusted prevalence ratios (PRs) for DPN, and spline models to examine the association with HOMA2-B and HOMA2-S. RESULTS: A total of 3,397 (77%) patients filled in the MNSIq. The prevalence of DPN was 23% among hyperinsulinemic, 16% among classical, and 14% among insulinopenic patients. After adjusting for demographics, diabetes duration and therapy, lifestyle behaviors, and metabolic syndrome components (waist circumference, triglycerides, HDL cholesterol, hypertension, and HbA1c), the PR of DPN was 1.35 (95% CI 1.15-1.57) for the hyperinsulinemic compared with the classical patients. In spline analyses, we observed a linear relation of higher DPN prevalence with increasing HOMA2-B, independent of both metabolic syndrome components and HOMA2-S. CONCLUSIONS: Hyperinsulinemia marked by high HOMA2-B is likely an important risk factor for DPN beyond metabolic syndrome components and insulin resistance. This should be considered when developing interventions to prevent DPN.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kristensen FPB, Christensen DH, Callaghan BC, et al. The Prevalence of Polyneuropathy in Type 2 Diabetes Subgroups Based on HOMA2 Indices of β-Cell Function and Insulin Sensitivity. Diabetes Care. 2023. PMID: 37335990. doi:10.2337/dc23-0079

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。